Episode Details
Back to Episodes
Switching ART in a Virologically Suppressed Person With Suspected Underlying Resistance
Description
In this episode, Timothy J. Wilkin, MD, MPH, provides a case-based overview of switching antiretroviral therapy in a patient with viral suppression on their current regimen who has a history of virologic failure with drug-resistance mutations. Key findings from 2 relevant studies—the SWITCHMRK trial and Study 380-4030—are reviewed. The case discussion also highlights several other challenges that can be encountered in the switch setting, including incomplete immune recovery, comorbidities, and gastrointestinal intolerability of some antiretroviral drugs.
Presenter:
Timothy J. Wilkin, MD, MPH
Professor Medicine
Division of Infectious Diseases
Weill Medical College of Cornell University
New York, New York
Content based on an online CME/CE program supported by an independent educational grant from ViiV Healthcare.
Link to full program:
https://bit.ly/3VIsDTg
Follow along with the slides at
https://bit.ly/3DdP3F6
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.